International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts

Yousef Khani 1 , Hojatoolah Barati 1 , Abolfaz Mollajan 1 , Mahshid Mojtahedzadeh Faghihi 2 and Shahnaz Rimaz 3 , *
Authors Information
1 Deputy of Health, Alborz University of Medical Sciences, Karaj, IR Iran
2 Department of Psychology, International Campus of Kharazmi University, Karaj, IR Iran
3 Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: March 2018, 7 (1); e66880
  • Published Online: February 13, 2018
  • Article Type: Research Article
  • Received: April 27, 2016
  • Revised: February 15, 2017
  • Accepted: April 24, 2017
  • DOI: 10.5812/ijhrba.66880

To Cite: Khani Y, Barati H, Mollajan A, Mojtahedzadeh Faghihi M, Rimaz S. Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts, Int J High Risk Behav Addict. 2018 ; 7(1):e66880. doi: 10.5812/ijhrba.66880.

Copyright © 2018, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Costa e Silva JA. Evidence-based analysis of the worldwide abuse of licit and illicit drugs. Hum Psychopharmacol. 2002;17(3):131-40. doi: 10.1002/hup.378. [PubMed: 12404690].
  • 2. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-99. doi: 10.1111/j.1360-0443.2009.02564.x. [PubMed: 19426289].
  • 3. United Nations Office on Drugs and Crime (UNODC) . World Drug Report 2010. United Nations publication, Sales No E.10.XI.13; 2010.
  • 4. United Nations Office on Drugs and Crime (UNODC) . World Drug Report 2014. United Nations publication, Sales No. E.14.XI.7; 2014.
  • 5. Moharreri MR. The International Challenge of Drug Abuse. General view of drug abuse in Iran, and a one-year report of out- patient treatment of opiate addiction in the city of Shiraz. Rockville: NIDA Research Monograph 19; 1978.
  • 6. Narenjiha H, Rafiey H, Baghestani AH. Rapid situation assessment of drug abuse and drug dependence in Iran. Tehran: Darius Institute; 2005.
  • 7. Barooni S, Mehrdad R, Akbari E. A survey of Ecstasy use among 15-25 year-olds in five areas of Tehran [In Persian]. Tehran Univ Med J. 2008;65(11):49-54.
  • 8. Mohtasham-Amiri Z, Jafari-Shakib A, Khalili-Moosavi A. Prevalence and factors associated with Ecstasy use among college undergraduates in north of Iran-2005. Asian J Psychiatr. 2011;4(1):31-4. doi: 10.1016/j.ajp.2011.01.004. [PubMed: 23050911].
  • 9. Moasheri N, Miri M, Mashreghi Moghadam HM, Eslami MR. A Study of Birjand University students' knowledge and attitude towards taking Ecstasy pills [In Persian]. J Birjand Univ Med Sci. 2007;13(4):9-15.
  • 10. Barati M, Allahverdipour H, Jalilian F. Prevalence and predictive factors of psychoactive and hallucinogenic substance abuse among college students [In Persian]. J Fund Ment Health. 2012;13(4):347-83.
  • 11. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci. 2004;1025:446-57. doi: 10.1196/annals.1316.055. [PubMed: 15542748].
  • 12. Samii AW. Drug abuse: Iran's 'thorniest problem'. Brown J World Aff. 2003;9(2):283.
  • 13. Murray JB. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol. 1998;132(2):227-37. doi: 10.1080/00223989809599162. [PubMed: 9529666].
  • 14. Brecht ML, von Mayrhauser C, Anglin MD. Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs. 2000;32(2):211-20. doi: 10.1080/02791072.2000.10400231. [PubMed: 10908010].
  • 15. Koob GF, Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. [PubMed: 18653439].
  • 16. Newton TF, De La Garza R2, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict. 2009;18(4):294-300. doi: 10.1080/10550490902925920. [PubMed: 19444733].
  • 17. Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3137-46. doi: 10.1098/rstb.2008.0093. [PubMed: 18640920].
  • 18. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol. 2003;6(4):347-52. doi: 10.1017/S1461145703003675. [PubMed: 14604449].
  • 19. Klee H. Amphetamine Misuse. Amphetamine misusers in contemporary Britain: The emergence of a hiddenpopulation: International Perspectiveson Current trends. In: Klee H, editor. Amsterdam: Harwood Academic Publishers; 1997.
  • 20. Gossop MR, Bradley BP, Brewis RK. Amphetamine withdrawal and sleep disturbance. Drug Alcohol Depend. 1982;10(2-3):177-83. doi: 10.1016/0376-8716(82)90010-2. [PubMed: 7166130].
  • 21. Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust N Z J Psychiatry. 1999;33(1):89-93. doi: 10.1046/j.1440-1614.1999.00517.x. [PubMed: 10197890].
  • 22. Churchill AC, Burgess PM, Pead J, Gill T. Measurement of the severity of amphetamine dependence. Addiction. 1993;88(10):1335-40. doi: 10.1111/j.1360-0443.1993.tb02019.x. [PubMed: 8251870].
  • 23. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320-9. doi: 10.1111/j.1360-0443.2005.01160.x. [PubMed: 16128721].
  • 24. McGregor C, Srisurapanont M, Mitchell A, Longo MC, Cahill S, White JM. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment. J Subst Abuse Treat. 2008;34(4):443-9. doi: 10.1016/j.jsat.2007.05.007. [PubMed: 17629443].
  • 25. World Health Organization . Process of translation and adaptation of instruments. World Health Organization; 2010.
  • 26. Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. Springer Publishing Company; 2010.
  • 27. Bagheri M, Mokri A, Khosravi A, Kabir K. Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community. Int J High Risk Behav Addict. 2015;4(3). e23903. doi: 10.5812/ijhrba.23903. [PubMed: 26495258].
  • 28. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, et al. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010;105(10):1809-18. doi: 10.1111/j.1360-0443.2010.03066.x. [PubMed: 20840201].
  • 29. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus. 2008;29(3):31-49. doi: 10.1080/08897070802218554. [PubMed: 19042205].
  • 30. Hartz DT, Frederick-Osborne SL, Galloway GP. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend. 2001;63(3):269-76. doi: 10.1016/S0376-8716(00)00217-9. [PubMed: 11418231].
  • 31. Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, et al. Status of methamphetamine users 2-5 years after outpatient treatment. J Addict Dis. 2002;21(1):107-19. doi: 10.1300/J069v21n01_09. [PubMed: 11831496].
  • 32. Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry. 1972;129(3):263-9. doi: 10.1176/ajp.129.3.263. [PubMed: 4340897].
  • 33. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, et al. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict. 2008;17(1):24-7. doi: 10.1080/10550490701756070. [PubMed: 18214719].
  • 34. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, et al. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict. 2008;17(3):218-23. doi: 10.1080/10550490802019774. [PubMed: 18463999].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments